Bain Capital-backed Emcure Pharmaceuticals is scheduled to launch its IPO on July 3, with the initial share sale concluding on July 5. Anchor investor bidding will open on July 2, as per the Red Herring Prospectus. The IPO consists of a fresh issuance of equity shares totaling Rs 800 crore and an OFS of 1.14 crore equity shares by promoters and existing shareholders. Among those participating in the OFS are promoter Satish Mehta and BC Investments IV Ltd, an affiliate of Bain Capital.
Comments
Post a Comment